Stemgenics
Seattle, US
Biotech
Founders & leadership
FS
Frederick S HagenExecutive Officer, Director
AS
Andranik S AprikyanExecutive Officer, Director
MS
Mushegh S HovhannisyanExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$445KraisedJul 2018 · 8 investors · Biotechnology
Rule 506(b)$1.8MraisedJan 2018 · 39 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.